Hematologic Improvement-Neutrophil and -Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions
Garcia-Manero G., Mufti G. J., Fenaux P., Buckstein R., Santini V., Diez-Campelo M., ...More
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text)
-
Publication Type:
Conference Paper / Summary Text
-
Volume:
134
-
Doi Number:
10.1182/blood-2019-123048
-
City:
Florida
-
Country:
United States Of America
-
Ankara University Affiliated:
Yes